High materiality8/10
PTC Therapeutics price target raised to $106 from $93 at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo raises PTCT target to $106 from $93; current price is $75.52. Upside implied by Wells Fargo target.
- Target to $106; price $75.52; Wells Fargo update.
Key facts
- 01
Target: $106
- 02
Posted price: $75.52
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.